Skip to content

Merge Hemo

by Merge Healthcare Incorporated United States 510(k)

510(k) K152864 Product code DQK

Overview

The Merge Hemo is a Radiation-Emitting Product classified under X-Ray Assembler (Product Code: DQK), designed to display, measure, and record physiological data during invasive catheter-based diagnostic and interventional procedures. It integrates with imaging systems to provide real-time hemodynamic monitoring, supporting cardiovascular assessments in clinical settings.

This device is supplied as a reusable system and is intended for use in hospital or interventional radiology environments. It requires compliance with radiation safety standards and is regulated under FDA 510(k) clearance (K152864) for substantial equivalence in cardiovascular applications. No explicit sterility or single-use designation is noted in the available data.

Summary written by AI from registry data, 19 Sep 2026.Not verified

About this summary

This description and any FAQs on this page were generated automatically and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them.

Regulatory status

as of 25 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK152864 Date7 Apr 2016ClearedStatusActive

Coverage

1 jurisdiction

United States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

United States — FDA 510(k) Active

Recalls

2 recalls · FDA

    • Terminated Z-2387-2021 FDA Class II initiated 23 Jul 2021

    The firm identified a safety issue affecting the software associated with Merge Hemo versions 9.x and 10.x, used in combination with an HL7 lab interface.

    • Terminated Z-0350-2018 FDA Class II initiated 6 Apr 2017

    Merge is conducting a hardware recall (replacement) of Fellows "Mighty 8" Power Strip and TrippLite Power Strip due to overheat of input resistor causing the power strip to smoke.

Specification

510(k) · synced 22 Oct 2026

510(k) Number
FDA Product Code
DQK
Device Class
Class II
Regulation
21 CFR Part 870.1425
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Other devices from Merge Healthcare Incorporated

See all devices from Merge Healthcare Incorporated →

Questions

  • What types of clinical procedures is the Merge Hemo designed to support during real-time hemodynamic monitoring?

    The Merge Hemo is specifically designed to support invasive catheter-based diagnostic and interventional procedures in cardiovascular assessments. It integrates with imaging systems to provide real-time hemodynamic monitoring, making it useful for procedures where precise measurement of physiological data is critical, such as coronary angiography or other interventional radiology cases.

  • Is the Merge Hemo intended for single-use or reusable applications in a clinical setting?

    The Merge Hemo is supplied as a reusable system, meaning it is designed for repeated use in hospital or interventional radiology environments. This distinguishes it from single-use devices and aligns with its intended use in clinical settings where durability and repeated applications are necessary.

  • How is the Merge Hemo regulated, and what does its FDA clearance status indicate?

    The Merge Hemo is regulated under the FDA 510(k) clearance process, specifically with clearance number K152864. Its classification as a Radiation-Emitting Product (X-Ray Assembler, Product Code DQK) and the substantial equivalence determination indicate that it has been deemed equivalent to a legally marketed predicate device for cardiovascular applications, ensuring compliance with safety and performance standards.

  • What kind of environments is the Merge Hemo intended for, and what safety considerations apply?

    The Merge Hemo is intended for use in hospital or interventional radiology environments where invasive catheter-based procedures are performed. Due to its classification as a Radiation-Emitting Product, it must comply with radiation safety standards to ensure safe operation and minimize exposure risks during use.

Properties & raw data

Show properties, registry sources and raw records

Sources (1)

  • FDA 510(k) K152864 24 fields · synced 22 Oct 2026